These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37502536)

  • 1. Retracted: Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9783040. PubMed ID: 37502536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma.
    Ma J; Yao Y; Tao DT; Yin JY; Chen L; Cui Y; Wang Y; Hu CL; Tian MX; Wang Q
    Contrast Media Mol Imaging; 2022; 2022():4486104. PubMed ID: 36034202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9780526. PubMed ID: 38094439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9820871. PubMed ID: 38094444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9875478. PubMed ID: 38125198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach.
    Markers D
    Dis Markers; 2023; 2023():9836354. PubMed ID: 37744889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis.
    Markers D
    Dis Markers; 2023; 2023():9861260. PubMed ID: 37387768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9898076. PubMed ID: 37860331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Biogenic Analysis of the Effect of TERC on Cell Proliferation and Migration of Oral Squamous Cell Carcinoma under Digital Minimally Invasive Treatment.
    International BR
    Biomed Res Int; 2023; 2023():9798465. PubMed ID: 37388366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Analysis of the Role and Mechanism of ZEB1 in Regulating Cervical Carcinoma Progression via Modulating PD-1/PD-L1 Checkpoint.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9783548. PubMed ID: 37811258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Identification of Differentially Expressed Long Noncoding RNAs as Functional Biomarkers and Construction of Function Enrichment Network in Oral Squamous Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9820845. PubMed ID: 37565232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: LINC01116 Promotes Migration and Invasion of Oral Squamous Cell Carcinoma by Acting as a Competed Endogenous RNA in Regulation of MMP1 Expression.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9847941. PubMed ID: 37811260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: MCU That Is Transcriptionally Regulated by Nrf2 Augments Malignant Biological Behaviors in Oral Squamous Cell Carcinoma Cells.
    International BR
    Biomed Res Int; 2024; 2024():9840106. PubMed ID: 38230029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Comprehensive Analysis Identifies COL1A1, COL3A1, and POSTN as Key Genes Associated with Brain Metastasis in Patients with Breast Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9792857. PubMed ID: 37388119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retracted] Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway.
    Liu B; Cao G; Dong Z; Guo T
    Oncol Lett; 2024 Jun; 27(6):275. PubMed ID: 38690102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Bioinformatics Analysis Identifies
    Markers D
    Dis Markers; 2023; 2023():9894804. PubMed ID: 37886108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Integrated Bioinformatics Identifies FREM1 as a Diagnostic Gene Signature for Heart Failure.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9803720. PubMed ID: 38075139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: BID-Net: An Automated System for Bone Invasion Detection Occurring at Stage T4 in Oral Squamous Carcinoma Using Deep Learning.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9754061. PubMed ID: 38074376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9813418. PubMed ID: 37387737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9893453. PubMed ID: 37387739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.